Endocrine Disorders in Kidney Disease (eBook, PDF)
Diagnosis and Treatment
117,69 €
inkl. MwSt.
Sofort per Download lieferbar
Endocrine Disorders in Kidney Disease (eBook, PDF)
Diagnosis and Treatment
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This comprehensive book examines the complex interplay between endocrine and kidney disorders, and how this inter-relationship impacts patients with chronic kidney disease. Authored by experts in areas of endocrinology and nephrology, chapters cover a variety of topics, including diabetes, metabolic syndrome, thyroid dysfunction, gonadal disorders, dyslipidemia, mineral bone disorders, obesity, and pituitary disorders. These comorbidities are thoroughly examined and provide the clinician, researcher, and trainee with a greater understanding of the impact of endocrine disorders on kidney…mehr
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 6.76MB
- Upload möglich
Andere Kunden interessierten sich auch für
- Vitamin D in Chronic Kidney Disease (eBook, PDF)96,29 €
- Post-Transplant Lymphoproliferative Disorders (eBook, PDF)96,29 €
- Disorders of Blood Pressure Regulation (eBook, PDF)192,59 €
- Adolescents with Chronic Kidney Disease (eBook, PDF)96,29 €
- Ventricular-Assist Devices and Kidney Disease (eBook, PDF)106,99 €
- Polycystic Kidney Disease (eBook, PDF)85,59 €
- Core Concepts in Hypertension in Kidney Disease (eBook, PDF)90,94 €
-
-
-
This comprehensive book examines the complex interplay between endocrine and kidney disorders, and how this inter-relationship impacts patients with chronic kidney disease. Authored by experts in areas of endocrinology and nephrology, chapters cover a variety of topics, including diabetes, metabolic syndrome, thyroid dysfunction, gonadal disorders, dyslipidemia, mineral bone disorders, obesity, and pituitary disorders. These comorbidities are thoroughly examined and provide the clinician, researcher, and trainee with a greater understanding of the impact of endocrine disorders on kidney disease patients, the ability to identify persistent gaps in knowledge for future investigation, and move closer towards the goal of improving the health and survival of the chronic kidney disease population.
Produktdetails
- Produktdetails
- Verlag: Springer International Publishing
- Erscheinungstermin: 13. März 2019
- Englisch
- ISBN-13: 9783319977652
- Artikelnr.: 55477928
- Verlag: Springer International Publishing
- Erscheinungstermin: 13. März 2019
- Englisch
- ISBN-13: 9783319977652
- Artikelnr.: 55477928
Connie M. Rhee, MD, MSc, Assistant Professor of Medicine and Public Health, Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, California, USA
Kamyar Kalantar-Zadeh, MD, MPH, PhD, Professor of Medicine, Pediatrics, Public Health, and Nursing Sciences, Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, California, USA
Gregory A. Brent, MD, Professor of Medicine and Physiology, Division of Endocrinology, Diabetes and Hypertension, David Geffen School of Medicine at the University of California Los Angeles, and Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, USA
Kamyar Kalantar-Zadeh, MD, MPH, PhD, Professor of Medicine, Pediatrics, Public Health, and Nursing Sciences, Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, California, USA
Gregory A. Brent, MD, Professor of Medicine and Physiology, Division of Endocrinology, Diabetes and Hypertension, David Geffen School of Medicine at the University of California Los Angeles, and Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, USA
Section I. Diabetes, Insulin Resistance, and the Metabolic Syndrome.- Chapter 1: Insulin Resistance and the Metabolic Syndrome in Kidney Disease (e.g. the Cardiorenal Metabolic Syndrome).- Chapter 2: Diabetic Kidney Disease.- Chapter 3: Glucose Homeostasis and the Burnt-Out Diabetes Phenomenon in Patients with Kidney Disease.- Chapter 4: Glycemic Metrics and Targets in Kidney Disease.- Chapter 5: Diabetic Pharmacotherapies in Kidney Disease.- Chapter 6: Diabetes Mellitus and Renal Transplantation.- Section II. Thyroid Dysfunction.- Chapter 7: Evaluating Thyroid Function Tests in Patients with Kidney Disease.- Chapter 8: Thyroid Status and Outcomes in Kidney Disease.- Section III. Gonadal Disorders.- Chapter 9: Testosterone Deficiency and Other Testicular Disorders in Kidney Disease.- Chapter 10: Amenorrhea and Estrogen Disorders in Women with Kidney Disease.- Chapter 11: Pregnancy in Kidney Disease.- Section IV. Dyslipidemia.- Chapter 12: Lipid DisordersAssociated with Chronic Kidney Disease and Nephrotic Syndrome.- Chapter 13: Drugs for Treatment of Dyslipidemia Available in the US.- Section V. Mineral Bone Disorders.- Chapter 14: Calcium Homeostasis in Kidney Disease.- Chapter 15: Phosphorus Retention and Elevated FGF-23 in Chronic Kidney Disease.- Chapter 16: Vitamin D and Parathyroid Hormone in Kidney Disease.- Chapter 17: Management of Bone Disorders in Kidney Disease.- Chapter 18: Mineral and Bone Disorders Following Renal Transplantation.- Section VI. Obesity and Adipokines.- Chapter 19: Obeesity in Kidney Disease.- Chapter 20: Adiponectin and Leptin in Kidney Disease Patients.- Section VII. Other Pituitary Disorders.- Chapter 21: Growth Hormone Disorders and Abnormal Stature in Kidney Disease.- Chapter 22: Other Pituitary Disorders and Kidney Disease.- Chapter 23: Endocrine System in Acute Kidney Injury.- Chapter 24: Nutrition and Endocrine Disorders in Kidney Disease.
Section I. Diabetes, Insulin Resistance, and the Metabolic Syndrome.- Chapter 1: Insulin Resistance and the Metabolic Syndrome in Kidney Disease (e.g. the Cardiorenal Metabolic Syndrome).- Chapter 2: Diabetic Kidney Disease.- Chapter 3: Glucose Homeostasis and the Burnt-Out Diabetes Phenomenon in Patients with Kidney Disease.- Chapter 4: Glycemic Metrics and Targets in Kidney Disease.- Chapter 5: Diabetic Pharmacotherapies in Kidney Disease.- Chapter 6: Diabetes Mellitus and Renal Transplantation.- Section II. Thyroid Dysfunction.- Chapter 7: Evaluating Thyroid Function Tests in Patients with Kidney Disease.- Chapter 8: Thyroid Status and Outcomes in Kidney Disease.- Section III. Gonadal Disorders.- Chapter 9: Testosterone Deficiency and Other Testicular Disorders in Kidney Disease.- Chapter 10: Amenorrhea and Estrogen Disorders in Women with Kidney Disease.- Chapter 11: Pregnancy in Kidney Disease.- Section IV. Dyslipidemia.- Chapter 12: Lipid DisordersAssociated with Chronic Kidney Disease and Nephrotic Syndrome.- Chapter 13: Drugs for Treatment of Dyslipidemia Available in the US.- Section V. Mineral Bone Disorders.- Chapter 14: Calcium Homeostasis in Kidney Disease.- Chapter 15: Phosphorus Retention and Elevated FGF-23 in Chronic Kidney Disease.- Chapter 16: Vitamin D and Parathyroid Hormone in Kidney Disease.- Chapter 17: Management of Bone Disorders in Kidney Disease.- Chapter 18: Mineral and Bone Disorders Following Renal Transplantation.- Section VI. Obesity and Adipokines.- Chapter 19: Obeesity in Kidney Disease.- Chapter 20: Adiponectin and Leptin in Kidney Disease Patients.- Section VII. Other Pituitary Disorders.- Chapter 21: Growth Hormone Disorders and Abnormal Stature in Kidney Disease.- Chapter 22: Other Pituitary Disorders and Kidney Disease.- Chapter 23: Endocrine System in Acute Kidney Injury.- Chapter 24: Nutrition and Endocrine Disorders in Kidney Disease.
Section I. Diabetes, Insulin Resistance, and the Metabolic Syndrome.- Chapter 1: Insulin Resistance and the Metabolic Syndrome in Kidney Disease (e.g. the Cardiorenal Metabolic Syndrome).- Chapter 2: Diabetic Kidney Disease.- Chapter 3: Glucose Homeostasis and the Burnt-Out Diabetes Phenomenon in Patients with Kidney Disease.- Chapter 4: Glycemic Metrics and Targets in Kidney Disease.- Chapter 5: Diabetic Pharmacotherapies in Kidney Disease.- Chapter 6: Diabetes Mellitus and Renal Transplantation.- Section II. Thyroid Dysfunction.- Chapter 7: Evaluating Thyroid Function Tests in Patients with Kidney Disease.- Chapter 8: Thyroid Status and Outcomes in Kidney Disease.- Section III. Gonadal Disorders.- Chapter 9: Testosterone Deficiency and Other Testicular Disorders in Kidney Disease.- Chapter 10: Amenorrhea and Estrogen Disorders in Women with Kidney Disease.- Chapter 11: Pregnancy in Kidney Disease.- Section IV. Dyslipidemia.- Chapter 12: Lipid DisordersAssociated with Chronic Kidney Disease and Nephrotic Syndrome.- Chapter 13: Drugs for Treatment of Dyslipidemia Available in the US.- Section V. Mineral Bone Disorders.- Chapter 14: Calcium Homeostasis in Kidney Disease.- Chapter 15: Phosphorus Retention and Elevated FGF-23 in Chronic Kidney Disease.- Chapter 16: Vitamin D and Parathyroid Hormone in Kidney Disease.- Chapter 17: Management of Bone Disorders in Kidney Disease.- Chapter 18: Mineral and Bone Disorders Following Renal Transplantation.- Section VI. Obesity and Adipokines.- Chapter 19: Obeesity in Kidney Disease.- Chapter 20: Adiponectin and Leptin in Kidney Disease Patients.- Section VII. Other Pituitary Disorders.- Chapter 21: Growth Hormone Disorders and Abnormal Stature in Kidney Disease.- Chapter 22: Other Pituitary Disorders and Kidney Disease.- Chapter 23: Endocrine System in Acute Kidney Injury.- Chapter 24: Nutrition and Endocrine Disorders in Kidney Disease.
Section I. Diabetes, Insulin Resistance, and the Metabolic Syndrome.- Chapter 1: Insulin Resistance and the Metabolic Syndrome in Kidney Disease (e.g. the Cardiorenal Metabolic Syndrome).- Chapter 2: Diabetic Kidney Disease.- Chapter 3: Glucose Homeostasis and the Burnt-Out Diabetes Phenomenon in Patients with Kidney Disease.- Chapter 4: Glycemic Metrics and Targets in Kidney Disease.- Chapter 5: Diabetic Pharmacotherapies in Kidney Disease.- Chapter 6: Diabetes Mellitus and Renal Transplantation.- Section II. Thyroid Dysfunction.- Chapter 7: Evaluating Thyroid Function Tests in Patients with Kidney Disease.- Chapter 8: Thyroid Status and Outcomes in Kidney Disease.- Section III. Gonadal Disorders.- Chapter 9: Testosterone Deficiency and Other Testicular Disorders in Kidney Disease.- Chapter 10: Amenorrhea and Estrogen Disorders in Women with Kidney Disease.- Chapter 11: Pregnancy in Kidney Disease.- Section IV. Dyslipidemia.- Chapter 12: Lipid DisordersAssociated with Chronic Kidney Disease and Nephrotic Syndrome.- Chapter 13: Drugs for Treatment of Dyslipidemia Available in the US.- Section V. Mineral Bone Disorders.- Chapter 14: Calcium Homeostasis in Kidney Disease.- Chapter 15: Phosphorus Retention and Elevated FGF-23 in Chronic Kidney Disease.- Chapter 16: Vitamin D and Parathyroid Hormone in Kidney Disease.- Chapter 17: Management of Bone Disorders in Kidney Disease.- Chapter 18: Mineral and Bone Disorders Following Renal Transplantation.- Section VI. Obesity and Adipokines.- Chapter 19: Obeesity in Kidney Disease.- Chapter 20: Adiponectin and Leptin in Kidney Disease Patients.- Section VII. Other Pituitary Disorders.- Chapter 21: Growth Hormone Disorders and Abnormal Stature in Kidney Disease.- Chapter 22: Other Pituitary Disorders and Kidney Disease.- Chapter 23: Endocrine System in Acute Kidney Injury.- Chapter 24: Nutrition and Endocrine Disorders in Kidney Disease.